Humana Stock: Overvalued With Higher Enterprise Value (NYSE:

Humana’s stable performance in Q1 2022 was overshadowed by its weak capital structure. See why we recommend a hold rating for HUM stock.

Related Keywords

Louisiana , United States , Oklahoma , Wisconsin , South Carolina , Kentucky , Thomas Kelley , Clayton Dubler , Elevance Health Inc , Progyny Inc , Elevance Health , Louisiana Health Department , Cigna Corporation , Unitedhealth Group , Family Physicians Group , Humana Inc , Medicaid Services , Health Maintenance Organization , Humana Waterside Building , Medicare Advantaged , Molina Healthcare , Preferred Provider Organizations , Home Advantage , Personal Care ,